A-M. C. Dingemans - Pulmonology Department, Erasmus MC - University Medical Center

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 8 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

S F Oosting,A A M van der Veldt, R S N Fehrmann,A Bhattacharya,R S van Binnendijk, C H GeurtsvanKessel,A-M C Dingemans,E F Smit, T J N Hiltermann,G den Hartog, M Jalving, T T Westphal,

ESMO openno. 4 (2023): 101599-101599

引用1浏览0WOS引用

OTP, CD44, and Ki-67-A prognostic marker panel for relapse free survival in patients with surgically resected pulmonary carcinoid

L. Moonen, J. Derks,M. Den Bakker, L. Hillen,J. Von der Thusen,Suylen R. J. Van, R. Damhuis, K. Smits, W. Buikhuisen, P. Group,A. M. Dingemans, E. J. Speel

JOURNAL OF NEUROENDOCRINOLOGY (2023): 147-147

引用0浏览0引用

Radiological follow- up (FU) in resected pulmonary typical carcinoids (pTC) - Do the benefits outweigh the risks

F. Heijboer, T. Mulders, Straten M. Van, L. Moonen, E. J. Speel,J. Von der Thusen, J. Derks,A. M. Dingemans

JOURNAL OF NEUROENDOCRINOLOGY (2023): 160-160

引用0浏览0引用

48P Efficacy of osimertinib (osi) on (prevention of) bone metastases (mets) and skeletal related events (SREs) in patients (pts) with epidermal growth factor receptor mutated (EGFRm+) non-small cell lung cancer (NSCLC)

A. Brouns,A.V. Veelen, M. Veerman, C. Steendam, S. Dursun, S. Croes,A-M.C. Dingemans,L. Hendriks

Annals of Oncology（2022）

引用0浏览0引用

Patterns of disease recurrence in relation to the extent of lymph node sampling in patients with resected lung carcinoid: A population-based study

J. Derks, L. Moonen,L. Hillen,R. J. van Suylen,M. den Bakker,J. von der Thusen, R. Damhuis, W. A. Buikhuisen,E. van den Broek, J. Maessen, L. P. W. M. Maat, P. E. van Schil,

ANNALS OF ONCOLOGY（2022）

引用0浏览0引用

Vaccination Against Sars-Cov-2 In Patients Receiving Chemotherapy, Immunotherapy, Or Chemo-Immunotherapy For Solid Tumors

S. Oosting,A. A. M. Van Der Veldt,C. H. Geurtsvankessel,R. S. N. Fehrmann,R. S. Van Binnendijk,A-M. C. Dingemans, E. F. F. Smit, T. J. N. Hiltermann,G. Den Hartog, M. Jalving, T. Westphal, A. Battacharya,

ANNALS OF ONCOLOGY（2021）

引用14浏览0引用

A Randomized Phase Iii Study Comparing Cisplatin-Pemetrexed (Cis-Pem) With Carboplatin (C)-Paclitaxel (P)-Bevacizumab (B) In Chemotherapy Naive Patients (Pts) With Advanced Kras Mutated Non-Small Cell Lung Cancer (Nsclc): Nvalt22

A-M. C. Dingemans, S. Ernst, W. Mellema,S. Burgers,J. Staal-Van Den Brekel,L. E. L. Hendriks, T. J. N. Hiltermann, N. Van Walree, K. Maas, M. Youssef-Elsoud, B. Biesma, V. Van Noord,

ANNALS OF ONCOLOGY（2021）

引用2浏览0引用

LBA50 A randomized phase III study comparing cisplatin-pemetrexed (cis-pem) with carboplatin (C)-paclitaxel (P)-bevacizumab (B) in chemotherapy naïve patients (pts) with advanced KRAS mutated non-small cell lung cancer (NSCLC): NVALT22

A-M.C. Dingemans, S. Ernst, W. Mellema, S. Burgers,J. Staal-van den Brekel, L.E.L. Hendriks, T.J.N. Hiltermann, N. van Walree, K. Maas, M. Youssef-ElSoud, B. Biesma, V. van Noord,

Annals of Oncology (2021): S1327

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn